| Differential general sales tax (GST) treatment between medical devices & pharmaceutical products | ||
| Reform ID | F714 | |
| Description | Under the Sales Tax Act, 1990, medical devices are taxed at 18% GST while pharmaceuticals are taxed at reduced rate of 1%. This creates a structural anomaly—treating essential clinical tools as luxury goods thereby inflating healthcare costs and burdening patients, hospitals, and public agencies. | |
| Department | Federal Board of Revenue - FBR-IRS | |
| Jurisdiction / Location | Federal - Entire Pakistan | |
| Sector | All Sectors | |
| Start Date | 03-06-2026 | |
| Target Deadline | ||
| Date Enacted | ||
| Implementation Status | In Progress | |
| Progress | 0% | |
| CCORR Direction | ||
| Cost Savings PKR (Mil.) | ||
| Evidence | ||
